PCSK9-IN-20 is a potent PCSK9 inhibitor with an IC50 of 3.96 µM. This compound effectively reduces PCSK9 levels and upregulates LDL receptor (LDLR) expression in vitro. It serves as a valuable tool for research applications focused on cholesterol metabolism and cardiovascular disease mechanisms.
PCSK9-IN-20 is a potent PCSK9 inhibitor with an IC50 of 3.96 µM. This compound effectively reduces PCSK9 levels and upregulates LDL receptor (LDLR) expression in vitro. It serves as a valuable tool for research applications focused on cholesterol metabolism and cardiovascular disease mechanisms.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: